Next 10 |
The terms of the distribution agreement allows ImmunoJuvenate to market an entire product catalogue under Private label in the United States, Canada and international markets West Caldwell, NJ and Toronto, Canada - ( NewMediaWire ) - May 17, 2021 - Eas...
EastGate Biotech ([[ETBI]]) has entered into a licensing and distribution agreement with Stenergy and Butero Farms for the company’s nutraceutical product, Glucora, for a licensing fee of $3M.Glucora, which is a highly efficient self-nanoemulsifying capsulation, is ...
The Licensing Fee of $3 Million USD to be Paid in a Combination of Cash and Sales-Driven Funding WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate Biotech Corp. (Other Markets OTC: Expert Markets: ETBI), a pharmaceutical com...
The Securities and Exchange Commission temporarily suspends trading of Eastgate Biotech ( OTCPK:ETBI ) securities due to concerns about "the adequacy and reliability of publicly available information concerning ETBI since at least Jan. 30, 2020 about, among other things, the company’...
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses WEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- /NEWMEDIAWIRE/ February 18, 2020/EastGate Biotech Corp. (OT...
Phoenix, Arizona--(Newsfile Corp. - February 5, 2020) - The Stock Day Podcast welcomed EastGate Biotech (OTC Pink: ETBI) ("the Company"), a company that focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are b...
WEST CALDWELL, NJ and TORONTO, ON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes...
WEST CALDWELL, NJ and TORONTO, ON, Dec. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes,...
WEST CALDWELL, NJ and TORONTO, ON, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, annou...
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s application, and Blood Plasma Derived Products, Human Serum Albumin 20% WEST CALDWELL, NJ and TORONTO, ON, Oct. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMED...
News, Short Squeeze, Breakout and More Instantly...
Eastgate Biotech Corp Company Name:
ETBI Stock Symbol:
OTCMKTS Market:
Eastgate Biotech Corp Website:
The terms of the distribution agreement allows ImmunoJuvenate to market an entire product catalogue under Private label in the United States, Canada and international markets West Caldwell, NJ and Toronto, Canada - ( NewMediaWire ) - May 17, 2021 - Eas...
The Licensing Fee of $3 Million USD to be Paid in a Combination of Cash and Sales-Driven Funding WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate Biotech Corp. (Other Markets OTC: Expert Markets: ETBI), a pharmaceutical com...
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses WEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- /NEWMEDIAWIRE/ February 18, 2020/EastGate Biotech Corp. (OT...